Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
Guidance Documents/Guidance-Document/ANDAs: Impurities in Drug Substances: Guidance for Industry

ANDAs: Impurities in Drug Substances: Guidance for Industry

Detailed guidance document from FDA and regulatory agencies.

Document Details

Guidance Document

July 15, 2009

November 27, 2024

Center for Drug Evaluation and Research

f8f33332-d6b5-44e6-a308-aa86ea6fa74f

Related Documents

ANDAs: Stability Testing of Drug Substances and Products, Questions and Answers

Guidance DocumentMay 15, 2014Center for Drug Evaluation and Research
View Details →

ANDAs: Stability Testing of Drug Substances and Products

Guidance DocumentJune 20, 2013Center for Drug Evaluation and Research
View Details →

ANDAs: Impurities in Drug Products: Guidance for Industry

Guidance DocumentNovember 29, 2010Center for Drug Evaluation and Research
View Details →

Quick Actions

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.

KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.